3
Announcements
Trials
Browse
Landscape
Status
Completed
803
Recruiting
537
Unknown
265
Terminated
255
Active not recruiting
120
Not yet recruiting
114
Withdrawn
32
Suspended
12
Enrolling by invitation
8
No longer available
7
Available
2
Approved for marketing
1
Sponsor Class
INDUSTRY
2
Study Type
Expanded_access
2
Sponsor
Cancer Type
Lymphoid
12
Thoracic
9
Genitourinary
9
Gastrointestinal
9
Sarcoma
8
Other hematologic neoplasm
8
CNS
8
Tumor-Agnostic
7
Plasma cell
5
Myeloid
5
Dermatologic
5
Breast
5
Gynecologic
4
Other solid neoplasm
2
Head & Neck
2
Endocrine
1
Conditions
Solid Tumors
1
Advanced Solid Tumor Cancer
1
Interventions
osunprotafib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Available
×
INDUSTRY
×
Other solid neoplasm
×
Clear all
NCT05982873
2026-02-06
Expanded Access to Telisotuzumab Adizutecan
AbbVie
Available
NCT06188975
2024-01-03
Expanded Access to ABBV-CLS-484
Calico Life Sciences LLC
Available